Posts Tagged ‘Potential’

FDA denies accelerated approval for ImmunoGen, Genentech potential breast cancer treatment

FDA denies accelerated approval for ImmunoGen, Genentech potential breast cancer treatment
WALTHAM, Mass. – Federal regulators have ruled that a potential breast cancer treatment from ImmunoGen failed to meet the standard for accelerated approval, the company said Friday.

Read more on Minneapolis-St. Paul Star Tribune

Medicaid Help a Potential Lifeline for State Breast Cancer Programs

Medicaid Help a Potential Lifeline for State Breast Cancer Programs
WASHINGTON, D.C.—-The Susan G. Komen for the Cure® Advocacy Alliance thanked Congress and the Administration for a six-month extension of enhanced federal funding for Medicaid, which was signed into law Tuesday night.

Read more on Business Wire via Yahoo! Finance

Provectus Pharmaceuticals to Use Numoda’s TruPoints System to Facilitate Transactions with Potential Licensing …

Provectus Pharmaceuticals to Use Numoda’s TruPoints System to Facilitate Transactions with Potential Licensing …
KNOXVILLE, Tenn.—-Provectus Pharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company, has signed an agreement with Numoda Capital Innovations LLC to license its TruPoints® strategic partnering platform.

Read more on Business Wire via Yahoo! Finance

Shares jump for potential targets of Sanofi deal

Shares jump for potential targets of Sanofi deal
FILE – In this May 12, 2009 file photo, Sanofi CEO Chris Viehbacher, delivers his speech during the launch of Sanofi Pasteur’s new plant. Rumors French pharmaceutical giant Sanofi-Aventis SA is chasing a big U.S. acquisition Friday, July 2, 2010, have driven up shares of companies investors think might be a target.(AP Photo/Laurent Cipriani, file)

Read more on Ventura County Star

A Potential new Breakthrough for Breast Cancer

Get the facts about Zometa, a new bone loss drug that may decrease your chances at breast cancer recurrence. Not yet used by doctors, Zometa is still undergoing clinical trials and may cause certain side effects.

Chronix’s serum DNA assays have potential to detect early stage breast cancer, prostate cancer

Chronix’s serum DNA assays have potential to detect early stage breast cancer, prostate cancer
Chronix Biomedical today reported new data further demonstrating that its serum DNA blood tests have the potential to accurately detect early stage breast cancer and prostate cancer. Chronix’s proprietary technology identifies disease-specific genetic fingerprints based on circulating DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells.

Read more on News-Medical-Net

Waiter, there’s a potential carcinogen in my soup

Waiter, there’s a potential carcinogen in my soup
BPA, or bisphenol A, is ubiquitous. Simply put, just about anything you eat that comes out of a can — from Campbell’s Chicken Soup and SpaghettiOs to Diet Coke and BumbleBee Tuna — contains the same exact chemical — and the exposure to BPA from canned food “is far more extensive” than from plastic bottles.

Read more on ABS-CBNNEWS.com

Wellstat Investigational Drug Shows Life-Saving Potential In Treating Toxicity Of Widely Used Cancer Chemotherapy

Wellstat Investigational Drug Shows Life-Saving Potential In Treating Toxicity Of Widely Used Cancer Chemotherapy
Wellstat Therapeutics announced today that the company’s investigational drug uridine triacetate has further demonstrated its life-saving potential in treating patients overexposed to the widely used cancer chemotherapy 5-fluorouracil (5-FU), according to clinical data to be presented June 7 at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.1 The National …

Read more on Medical News Today

Over 30 Scientific Presentations at ASCO Exploring ABRAXANE’s Expanded Potential in Multiple Difficult-to-Treat Cancers

Over 30 Scientific Presentations at ASCO Exploring ABRAXANE’s Expanded Potential in Multiple Difficult-to-Treat Cancers
LOS ANGELES—-Abraxis BioScience, Inc. today announced that 32 scientific abstracts will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology , June 4-8 in Chicago, evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel .

Read more on Business Wire via Yahoo! Finance

Potential Complications of Breast Augmentation Surgery

Complications of breast augmentation surgery are rare and most patients report that the pain and discomfort associated with the recovery are definitely worth the benefits. But, as with any surgery, it is very important to be well educated about the potential complications before you go through with the surgery. You and your cosmetic surgeon should discuss in detail the complications listed below and all questions you have prior to your procedure.

Capsular Contracture – this condition, which can cause some pain and discomfort, occurs if the connective tissue around the implant tightens, giving your new breasts an unnaturally firm look and feel. If severe capsular contracture happens after your breast augmentation surgery, it may require another surgery to remove the connective tissue and replace the implant.

This condition is less common if the implant is placed behind the muscle, so be sure to discuss this with your cosmetic surgeon prior to the procedure.

Implant Displacement – Although rare, your new breast implants can shift out of position after the surgery. They can move up or down or left or right. If an implant only shifts slightly, it may not be noticeable. If it shifts a lot, you may need corrective surgery to move it back to the right position.

Rupture – Whether you have saline or silicone implants, they can sometimes rupture after surgery. If you have saline implants, the saline (sterile salt water) will leak out and be absorbed by the body, with no resulting harm. The implant can then be replaced. Surprisingly, rupture and deflation is most common when the implants have NOT been overfilled. This concept is counterintuitive, but rupture happens when a small section of the implant shell folds repeatedly due to your natural body movements. Eventually the area where it keeps folding can form a tiny tear and then the saline will leak out, causing the implant to deflate.

The risk of deflation is about 4% during the first year after the implants are put in and then goes down to 1% per year per implant after that.

The same body movements that cause a saline implant to rupture can also cause a silicone implant to rupture. The major difference is that with the new silicone gel implants approved in 2006 by the FDA, the silicone does not leak. It sticks to itself despite the small tear in the shell. Therefore you may not know that the implant has ruptured. In some cases the body can create capsular contracture after a rupture. Once you are aware that your silicone implant has ruptured, you will need to have it taken out along with any tightened connective tissue the rupture has caused, and have it replaced.

Rippling – Rippling is wrinkling or waviness of the skin over the saline implant. It is caused by the saline shifting inside of the implant, and for that reason, is very uncommon if the implant is overfilled. Placing the implant under the muscle will also reduce your chances of having this complication.

Infection – In roughly 1% of all breast augmentation procedures an infection will occur within the first two months. If this happens, you will need to go on antibiotics and it may require implant removal. Carefully following your post-surgery self-care instructions will go a long way towards preventing any infection.

Nipple Numbness – The risk for some level of nipple numbness is about 15% for breast augmentation patients in the U.S. Although many cosmetic surgeons have a much lower percentage of patients who have experienced this problem, this should be a major consideration before you schedule your surgery. Talk with your cosmetic surgeon about this risk in detail and ask how many of his or her patients have ever experienced it.

Mammogram Interference – The most effective way to detect breast cancer is through self-exams, which your implants will not interfere with. But implants can interfere with mammograms, because they block the view of roughly 10-25% of your breast tissue, depending on whether your implant is over or under the muscle (under the muscle interferes the least). If this is a major concern for you, you should discuss it with both your cosmetic surgeon and OBGYN.